273 related articles for article (PubMed ID: 18537664)
1. Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology.
Hoozemans JJ; Rozemuller JM; van Haastert ES; Veerhuis R; Eikelenboom P
Curr Pharm Des; 2008; 14(14):1419-27. PubMed ID: 18537664
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
[TBL] [Abstract][Full Text] [Related]
3. The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.
Hoozemans JJ; O'Banion MK
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):307-15. PubMed ID: 15975032
[TBL] [Abstract][Full Text] [Related]
4. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
5. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
6. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
8. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
McGeer PL
Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
Pasinetti GM
J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs.
Ferencik M; Novak M; Rovensky J; Rybar I
Bratisl Lek Listy; 2001; 102(3):123-32. PubMed ID: 11433600
[TBL] [Abstract][Full Text] [Related]
12. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
13. [Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
Shen JN; Xu LX; Wang R
Yao Xue Xue Bao; 2013 Dec; 48(12):1743-54. PubMed ID: 24689230
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory drugs: a hope for Alzheimer's disease?
Hüll M; Lieb K; Fiebich BL
Expert Opin Investig Drugs; 2000 Apr; 9(4):671-83. PubMed ID: 11060701
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.
Thomas T; Nadackal TG; Thomas K
Neuroreport; 2001 Oct; 12(15):3263-7. PubMed ID: 11711868
[TBL] [Abstract][Full Text] [Related]
16. Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?
Ho L; Qin W; Stetka BS; Pasinetti GM
CNS Drugs; 2006; 20(2):85-98. PubMed ID: 16478285
[TBL] [Abstract][Full Text] [Related]
17. [The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease].
Cakała M; Strosznajder JB
Neurol Neurochir Pol; 2010; 44(1):65-79. PubMed ID: 20358486
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease.
Qin W; Peng Y; Ksiezak-Reding H; Ho L; Stetka B; Lovati E; Pasinetti GM
Mol Psychiatry; 2006 Feb; 11(2):172-81. PubMed ID: 16331303
[TBL] [Abstract][Full Text] [Related]
20. Deficiency in either COX-1 or COX-2 genes does not affect amyloid beta protein burden in amyloid precursor protein transgenic mice.
Park SA; Chevallier N; Tejwani K; Hung MM; Maruyama H; Golde TE; Koo EH
Biochem Biophys Res Commun; 2016 Sep; 478(1):286-292. PubMed ID: 27425247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
